Physician

Brendan O'Neill, M.D.

According to 2025 Medicare claims, Brendan O'Neill, M.D. (NPI: 1013170695) practices dermatology in the Flagstaff, AZ market, with the plurality of this provider's patient population coming from Coconino, AZ. This provider's primary affiliated billing organization is NORTHERN ARIZONA DERMATOLOGY CENTER PC (NPI: 1962558569; TIN: 860309409) and primary practice location at 86001-1383.

O'Neill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,066 traditional Medicare patients, billed 7,641 HCPCS/CPT codes, and received $416,555 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 521 prescription claims across 223 beneficiaries totaling $195,466 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 30 records totaling $890. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $176,113 to $416,555. Similarly, Part D prescription costs have risen steadily, from $1,321 to $195,466. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$208K$417K2015 Medicare payment: $176,113 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $92,476 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $14,507 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $303,325 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $355,447 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $303,174 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $287,117 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $407,592 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $390,392 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $416,555 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,8823,267$176,113
20168981,655$92,476
201767323$14,507
20182,2505,577$303,325
20192,4766,445$355,447
20202,2115,601$303,174
20211,6414,785$287,117
20222,2047,405$407,592
20231,9006,818$390,392
20242,0667,641$416,555

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$98K$195K2016 Drug cost: $1,321 (USD; Tot_Drug_Cst)2017 Drug cost: $28,681 (USD; Tot_Drug_Cst)2018 Drug cost: $5,251 (USD; Tot_Drug_Cst)2019 Drug cost: $9,157 (USD; Tot_Drug_Cst)2020 Drug cost: $12,027 (USD; Tot_Drug_Cst)2021 Drug cost: $8,470 (USD; Tot_Drug_Cst)2022 Drug cost: $149,870 (USD; Tot_Drug_Cst)2023 Drug cost: $98,576 (USD; Tot_Drug_Cst)2024 Drug cost: $195,466 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161828$1,321
201759144$28,681
201865139$5,251
2019103239$9,157
202097285$12,027
2021127238$8,470
2022168401$149,870
2023178452$98,576
2024223521$195,466

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths276321$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more465609$55
88305Pathology examination of tissue using a microscope, intermediate complexity1,5532,430$51
17000Destruction of precancer skin growth, 1 growth350453$31
17003Destruction of precancer skin growth, 2-14 growths2891,765$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate36956$1,696
FluocinonideFluocinonide421,287$1,603
FluorouracilFluorouracil22678$1,372
MetronidazoleMetronidazole19520$1,140
Triamcinolone AcetonideTriamcinolone Acetonide892,814$1,069

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$890Dermavant Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brendan O'Neill, M.D.?

Tedicare shows public-source Medicare data for Brendan O'Neill, M.D. (NPI 1013170695), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brendan O'Neill, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brendan O'Neill, M.D.?

Brendan O'Neill, M.D. is linked to NORTHERN ARIZONA DERMATOLOGY CENTER PC (billing NPI 1962558569) in the available physician profile data.

Does Brendan O'Neill, M.D. have Open Payments data?

Brendan O'Neill, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.